Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Nat Med ; 13(2): 181-8, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17259996

RESUMEN

Excessive retinal vascular permeability contributes to the pathogenesis of proliferative diabetic retinopathy and diabetic macular edema, leading causes of vision loss in working-age adults. Using mass spectroscopy-based proteomics, we detected 117 proteins in human vitreous and elevated levels of extracellular carbonic anhydrase-I (CA-I) in vitreous from individuals with diabetic retinopathy, suggesting that retinal hemorrhage and erythrocyte lysis contribute to the diabetic vitreous proteome. Intravitreous injection of CA-I in rats increased retinal vessel leakage and caused intraretinal edema. CA-I-induced alkalinization of vitreous increased kallikrein activity and its generation of factor XIIa, revealing a new pathway for contact system activation. CA-I-induced retinal edema was decreased by complement 1 inhibitor, neutralizing antibody to prekallikrein and bradykinin receptor antagonism. Subdural infusion of CA-I in rats induced cerebral vascular permeability, suggesting that extracellular CA-I could have broad relevance to neurovascular edema. Inhibition of extracellular CA-I and kallikrein-mediated innate inflammation could provide new therapeutic opportunities for the treatment of hemorrhage-induced retinal and cerebral edema.


Asunto(s)
Permeabilidad Capilar/efectos de los fármacos , Inhibidores de Anhidrasa Carbónica/uso terapéutico , Anhidrasas Carbónicas/metabolismo , Retinopatía Diabética/tratamiento farmacológico , Proteínas del Ojo/metabolismo , Sistema Calicreína-Quinina/fisiología , Cuerpo Vítreo/enzimología , Acetazolamida/farmacología , Animales , Western Blotting , Antagonistas de los Receptores de Bradiquinina , Inhibidores de Anhidrasa Carbónica/farmacología , Anhidrasas Carbónicas/toxicidad , Complemento C1/antagonistas & inhibidores , Factor XIIa/metabolismo , Humanos , Espectrometría de Masas , Papiledema/inducido químicamente , Proteómica , Ratas , Ratas Sprague-Dawley , Estadísticas no Paramétricas
2.
Retina ; 34(10): 1960-8, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24830822

RESUMEN

PURPOSE: To compare visual acuity outcomes and diabetic retinopathy progression after pars plana vitrectomy (PPV) versus combined pars plana vitrectomy and phacoemulsification (PPVCE) in patients with diabetes. METHODS: Retrospective review of 222 consecutive diabetic patients undergoing PPV or PPVCE. RESULTS: A total of 251 eyes of 222 patients were evaluated (PPV = 122, PPVCE = 129). Four-year follow-up was 64% (161 eyes). Overall, patients undergoing PPVCE had better preoperative visual acuity (PPVCE = 20/80, PPV = 20/160, P = 0.03). At 4-year follow-up, visual acuity improved (PPV = +22, PPVCE = +11 letters) compared with baseline in both groups. After correcting for baseline differences in visual acuity, no statistically significant difference in final visual acuity was observed (PPVCE = 20/32, PPV = 20/50, P = 0.09). Results did not differ substantially by surgical indication (vitreous hemorrhage, traction retinal detachment, epiretinal membrane, and/or diabetic macular edema). Cataract progression occurred in 64%, and cataract surgery was performed in 39% of phakic eyes undergoing PPV. Rates of diabetic retinopathy progression, vitreous hemorrhage, and retinal detachment were not statistically different. Neovascular glaucoma developed in 2 patients (2%) after PPV and 6 patients (8%) after PPVCE (P = 0.07). CONCLUSION: In diabetic patients, equivalent visual acuity improvement over 4 years was observed after PPV or PPVCE. Visual outcomes and retinopathy progression rates were not significantly different after either intervention, suggesting that PPVCE may be appropriate when indicated in patients with diabetes.


Asunto(s)
Retinopatía Diabética/cirugía , Implantación de Lentes Intraoculares , Facoemulsificación , Agudeza Visual/fisiología , Vitrectomía , Adulto , Anciano , Anciano de 80 o más Años , Diabetes Mellitus Tipo 1/complicaciones , Diabetes Mellitus Tipo 2/complicaciones , Retinopatía Diabética/diagnóstico , Retinopatía Diabética/fisiopatología , Progresión de la Enfermedad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Seudofaquia/fisiopatología , Estudios Retrospectivos , Tomografía de Coherencia Óptica
3.
Retina ; 30(9): 1488-95, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20924264

RESUMEN

PURPOSE: To evaluate factors ¶associated with favorable outcomes after vitrectomy for diabetic macular edema. METHODS: Data were collected prospectively on 241 eyes undergoing vitrectomy for diabetic macular edema. Multivariate models were used to evaluate associations of 20 preoperative and intraoperative factors with 6-month outcomes of visual acuity and retinal thickness. RESULTS: Median central subfield thickness decreased from 412 µm to 278 µm at 6 months, but median visual acuity remained unchanged (20/80, Snellen equivalent). Greater visual acuity improvement occurred in eyes with worse baseline acuity (P < 0.001) and in eyes in which an epiretinal membrane was removed (P = 0.006). Greater reduction in central subfield thickness occurred with worse baseline visual acuity (P < 0.001), greater preoperative retinal thickness (P = 0.001), removal of internal limiting membrane (P = 0.003), and optical coherence tomography evidence of vitreoretinal abnormalities (P = 0.006). No associations with clinician's preoperative assessments of the posterior vitreous were identified. CONCLUSION: These results suggest that the removal of epiretinal membranes may favorably affect visual outcome after vitrectomy. Preoperative presence of vitreoretinal abnormalities appeared to be associated with somewhat greater reductions in retinal thickness but not with visual acuity outcome. These results may be useful for future studies evaluating vitrectomy for diabetic macular edema.


Asunto(s)
Retinopatía Diabética/fisiopatología , Retinopatía Diabética/cirugía , Edema Macular/fisiopatología , Edema Macular/cirugía , Agudeza Visual/fisiología , Vitrectomía , Adulto , Anciano , Anciano de 80 o más Años , Membrana Basal , Membrana Epirretinal/fisiopatología , Membrana Epirretinal/cirugía , Femenino , Humanos , Complicaciones Intraoperatorias , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Retina/patología , Factores de Riesgo , Tomografía de Coherencia Óptica , Resultado del Tratamiento
4.
Semin Ophthalmol ; 33(1): 126-133, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29215958

RESUMEN

Despite recent advances in the medical management of diabetic retinal disease, there remain established indications for vitreoretinal surgery in the treatment of severe proliferative diabetic retinopathy. These include non-clearing vitreous hemorrhage and tractional retinal detachment. Advances in surgical instrumentation, technique, and experience have led to improved visual outcomes, as well as a corresponding decrease in the incidence of postoperative complications. However, the presence of systemic and ocular factors in diabetic patients increases the risk of adverse events compared to non-diabetic individuals. This review will focus on the most important postoperative complications following pars plana vitrectomy, with specific considerations for the diabetic patient.


Asunto(s)
Retinopatía Diabética/cirugía , Complicaciones Posoperatorias , Vitrectomía/efectos adversos , Humanos , Agudeza Visual
5.
Am J Ophthalmol ; 139(4): 719-21, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15808176

RESUMEN

PURPOSE: To report acute unilateral hypopyon uveitis as an initial presenting feature of relapsing acute lymphoblastic leukemia (ALL) in an adult patient. DESIGN: Observational case report. METHODS: Anterior chamber paracentesis was performed in a 56-year-old male presenting with treatment-resistant unilateral hypopyon while in the remission phase of ALL. RESULTS: Examination of the aqueous humor aspirate revealed presence of malignant cells compatible with the previous bone marrow biopsy and subsequent spinal tap results. CONCLUSIONS: Atypical hypopyon uveitis can be an indication of relapsing ALL, even in adults. Prompt anterior chamber aspiration is required for the correct diagnosis and subsequent treatment.


Asunto(s)
Cámara Anterior/patología , Neoplasias del Ojo/diagnóstico , Recurrencia Local de Neoplasia/diagnóstico , Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnóstico , Uveítis Anterior/diagnóstico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Humor Acuoso/citología , Células de la Médula Ósea/patología , Líquido Cefalorraquídeo/citología , Neoplasias del Ojo/tratamiento farmacológico , Neoplasias del Ojo/genética , Glaucoma/diagnóstico , Humanos , Presión Intraocular , Infiltración Leucémica , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/tratamiento farmacológico , Recurrencia Local de Neoplasia/genética , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Leucemia-Linfoma Linfoblástico de Células Precursoras/genética , Supuración/diagnóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA